Movement Alert｜GENSCRIPT B-1K Intraday Rise 8.48% in Regular Trading, institutional buying and CARVYKTI sales momentum support sentiment

Market Focus09:32

On October 28, GENSCRIPT B-1K recorded an Intraday Rise of 8.48% in Regular Trading, trading at HK$35.12, with turnover of HK$208 million.

The move is associated with continued support from recent institutional stake increases and sales momentum from core product CARVYKTI, which has helped sustain market sentiment.

Recent disclosures showed FIL Limited increased its holdings by about 10.47 million shares on October 16 at an average price of about HK$33.54 per share, involving roughly HK$351 million, lifting its stake to 9.26%. Earlier, FMR LLC increased holdings by about 4.74 million shares on October 15 at an average price of about HK$32.78 per share. Separately, the company disclosed that Legend Biotech's core product CARVYKTI generated about US$710 million in trade net sales for the September quarter, bringing sales for the first three quarters to about US$1.964 billion, up 47.4% year over year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment